Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Davide Capoferri"'
Autor:
Arianna Giacomini, Sara Taranto, Giorgia Gazzaroli, Jessica Faletti, Davide Capoferri, Raffaella Marcheselli, Margherita Sciumè, Marco Presta, Antonio Sacco, Aldo M. Roccaro
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 43, Iss 1, Pp 1-17 (2024)
Abstract Among blood cancers, multiple myeloma (MM) represents the second most common neoplasm and is characterized by the accumulation and proliferation of monoclonal plasma cells within the bone marrow. Despite the last few decades being characteri
Externí odkaz:
https://doaj.org/article/be64ebe462f54564880972f7b4f18a9a
Impact of an irreversible β-galactosylceramidase inhibitor on the lipid profile of zebrafish embryos
Autor:
Jessica Guerra, Mirella Belleri, Giulia Paiardi, Chiara Tobia, Davide Capoferri, Marzia Corli, Elisa Scalvini, Marco Ghirimoldi, Marcello Manfredi, Rebecca C. Wade, Marco Presta, Luca Mignani
Publikováno v:
Computational and Structural Biotechnology Journal, Vol 23, Iss , Pp 1397-1407 (2024)
Krabbe disease is a sphingolipidosis characterized by the genetic deficiency of the acid hydrolase β-galactosylceramidase (GALC). Most of the studies concerning the biological role of GALC performed on Krabbe patients and Galc-deficient twitcher mic
Externí odkaz:
https://doaj.org/article/c98712cfb14b4da3a4a44f64229c80dd
Autor:
Elisabetta Grillo, Cosetta Ravelli, Michela Corsini, Mattia Domenichini, Maria Scamozzi, Daniela Zizioli, Davide Capoferri, Roberto Bresciani, Chiara Romani, Stefania Mitola
Publikováno v:
European Journal of Cell Biology, Vol 103, Iss 4, Pp 151459- (2024)
Recent data shows that alterations in the expression and/or activation of the vascular endothelial growth factor receptor 2 (VEGFR2) in high grade serous ovarian cancer (HGSOC) modulate tumor progression. However, controversial results have been obta
Externí odkaz:
https://doaj.org/article/bfffba064f7349df8596eaec35341623
Publikováno v:
Data, Vol 8, Iss 12, p 177 (2023)
β-Galactosylceramidase (GALC) is a lysosomal enzyme involved in sphingolipid metabolism by removing β-galactosyl moieties from β-galactosyl ceramide and β-galactosyl sphingosine. Previous observations have shown that GALC exerts a pro-oncogenic a
Externí odkaz:
https://doaj.org/article/6ff7343f42894a6cac1838bfa7c0d545
Autor:
Eliana Bignotti, Laura Zanotti, Paola Todeschini, Valentina Zizioli, Chiara Romani, Davide Capoferri, Germana Tognon, Enrico Sartori, Stefano Calza, Franco Odicino, Antonella Ravaggi
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
In spite of the effective implementation of screening programs, uterine cervical carcinoma (UCC) remains one of the major causes of cancer death among women around the world. The aim of this study was to investigate the prognostic value of serum huma
Externí odkaz:
https://doaj.org/article/5130fb4b05f14aa4be9ad2d0f243407e
Autor:
Presta, Davide Capoferri, Paola Chiodelli, Marzia Corli, Mirella Belleri, Elisa Scalvini, Luca Mignani, Jessica Guerra, Elisabetta Grillo, Veronica De Giorgis, Marcello Manfredi, Marco
Publikováno v:
International Journal of Molecular Sciences; Volume 24; Issue 13; Pages: 10555
β-Galactosylceramidase (GALC) is a lysosomal enzyme involved in sphingolipid metabolism by removing β-galactosyl moieties from β-galactosylceramide and β-galactosylsphingosine. Previous observations have shown that GALC may exert pro-oncogenic fu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::362f182773975ac90489488543c99eab
Sphingolipidoses are inborn errors of metabolism due to the pathogenic mutation of genes that encode for lysosomal enzymes, transporters, or enzyme cofactors that participate in the sphingolipid catabolism. They represent a subgroup of lysosomal stor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72aa8be269e3e3905b69a7e379b19290
https://hdl.handle.net/11379/575885
https://hdl.handle.net/11379/575885
Autor:
Antonella Ravaggi, Davide Capoferri, Laura Ardighieri, Iacopo Ghini, Federico Ferrari, Chiara Romani, Mattia Bugatti, Laura Zanotti, Stephanie Vrede, Germana Tognon, Johanna M. A. Pijnenborg, Enrico Sartori, Stefano Calza, Eliana Bignotti, Franco Odicino
Publikováno v:
Cancers, 14
Cancers; Volume 14; Issue 21; Pages: 5429
Cancers, 14, 21
Cancers; Volume 14; Issue 21; Pages: 5429
Cancers, 14, 21
Contains fulltext : 287744.pdf (Publisher’s version ) (Open Access) Histopathologic assessment of high-risk endometrial cancer (EC) suffers from intersubject variability and poor reproducibility. The pragmatic classification in four molecular subgr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06fda58e3f824f51de18ec3f5b86eed5
http://hdl.handle.net/2066/287744
http://hdl.handle.net/2066/287744
Autor:
Chiara Romani, Davide Capoferri, Casper Reijnen, Silvia Lonardi, Antonella Ravaggi, Martina Ratti, Mattia Bugatti, Laura Zanotti, Germana Tognon, Enrico Sartori, Franco Odicino, Stefano Calza, Johanna M. A. Pijnenborg, Eliana Bignotti
Publikováno v:
International Journal of Cancer, 151, 637-648
International Journal of Cancer, 151, 4, pp. 637-648
International Journal of Cancer, 151, 4, pp. 637-648
Contains fulltext : 251438.pdf (Publisher’s version ) (Open Access) For high-risk endometrial cancer (EC) patients, adjuvant chemotherapy is recommended to improve outcome. Yet, predictive biomarkers for response to platinum-based chemotherapy (Pt-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b7f00df3de8b1512e023c347f33a212
http://hdl.handle.net/2066/251438
http://hdl.handle.net/2066/251438
Cell lines have always constituted a good investigation tool for cancer research, allowing scientists to understand the basic mechanisms underlying the complex network of phenomena peculiar to the transforming path from a healthy to cancerous cell. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4abc0d403addec0358cfca50769dc59
https://hdl.handle.net/11379/567224
https://hdl.handle.net/11379/567224